Works matching IS 03656233 AND DT 2023 AND VI 356 AND IP 2
Results: 16
Editorial Board: Arch Pharm (2/2023).
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 2, p. 1, doi. 10.1002/ardp.202370004
- Publication type:
- Article
Cover Picture: Arch Pharm (2/2023).
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 2, p. 1, doi. 10.1002/ardp.202370003
- Publication type:
- Article
Prevalence of nitrosamine contaminants in drug samples: Has the crisis been overcome?
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 2, p. 1, doi. 10.1002/ardp.202200484
- By:
- Publication type:
- Article
Replacing the oxidation‐sensitive triaminoaryl chemotype of problematic K<sub>V</sub>7 channel openers: Exploration of a nicotinamide scaffold.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 2, p. 1, doi. 10.1002/ardp.202200473
- By:
- Publication type:
- Article
Azobenzene derivatives with activity against drug‐resistant Candida albicans and Candida auris.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 2, p. 1, doi. 10.1002/ardp.202200463
- By:
- Publication type:
- Article
A comprehensive review on the antidiabetic attributes of thiazolidine‐4‐ones: Synthetic strategies and structure–activity relationships.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 2, p. 1, doi. 10.1002/ardp.202200452
- By:
- Publication type:
- Article
Tail approach synthesis of triazolylthiazolotriazole bearing benzenesulfonamides as carbonic anhydrase inhibitors capable of inducing apoptosis.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 2, p. 1, doi. 10.1002/ardp.202200439
- By:
- Publication type:
- Article
Novel benzenesulfonamide‐thiouracil conjugates with a flexible N‐ethyl acetamide linker as selective CA IX and CA XII inhibitors.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 2, p. 1, doi. 10.1002/ardp.202200434
- By:
- Publication type:
- Article
New chimeric HDAC inhibitors for the treatment of colorectal cancer.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 2, p. 1, doi. 10.1002/ardp.202200422
- By:
- Publication type:
- Article
Discovery of oxindole‐based FLT3 inhibitors as a promising therapeutic lead for acute myeloid leukemia carrying the oncogenic ITD mutation.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 2, p. 1, doi. 10.1002/ardp.202200407
- By:
- Publication type:
- Article
Discovery of novel pyrazole and pyrazolo[1,5‐a]pyrimidine derivatives as cyclooxygenase inhibitors (COX‐1 and COX‐2) using molecular modeling simulation.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 2, p. 1, doi. 10.1002/ardp.202200395
- By:
- Publication type:
- Article
Synthesis and biological evaluation of new quinoline‐4‐carboxylic acid‐chalcone hybrids as dihydroorotate dehydrogenase inhibitors.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 2, p. 1, doi. 10.1002/ardp.202200374
- By:
- Publication type:
- Article
New 1,3,4‐oxadiazole‐chalcone/benzimidazole hybrids as potent antiproliferative agents.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 2, p. 1, doi. 10.1002/ardp.202200357
- By:
- Publication type:
- Article
Chrysin: A polyedric flavone as a tool to explore new phytotherapeutic applications and drug design.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 2, p. 1, doi. 10.1002/ardp.202200347
- By:
- Publication type:
- Article
Novel 2‐oxo‐2‐phenylethoxy and benzyloxy diaryl urea hybrids as VEGFR‐2 inhibitors: Design, synthesis, and anticancer evaluation.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 2, p. 1, doi. 10.1002/ardp.202200341
- By:
- Publication type:
- Article
Discovery of new cinnamic derivatives as anti‐inflammatory agents for treating acute lung injury in mice.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 2, p. 1, doi. 10.1002/ardp.202200191
- By:
- Publication type:
- Article